Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.

Cook PJ, Thomas R, Kannan R, de Leon ES, Drilon A, Rosenblum MK, Scaltriti M, Benezra R, Ventura A
Nat Commun. 2017 Jul 11;8:15987. doi: 10.1038/ncomms15987. PubMed Article

Plasmids from Article

ID	Plasmid	Purpose
101823	Adeno BN	Adenovirus for the expression of gRNAs targeting intron 13 of murine Bcan and intron 10 of murine Ntrk1
101824	Adeno FT	Adenovirus for the expression of gRNAs targeting intron 17 of murine Fgfr3 and intron 6 of murine Tacc3